Molecular imaging, targeted therapeutics, and nanoscience

1 January 2002

journal article
review article
Published by Wiley in Journal of Cellular Biochemistry

Vol. 87 (S39) , 90-97
https://doi.org/10.1002/jcb.10422

Abstract

The recent emergence of “molecular imaging” as an academic discipline has set the stage for an evolutionary leap in diagnostic imaging. Recent advances in nuclear, ultrasound, optical, and magnetic resonance imaging have generated interest in molecular imaging across all modalities and across various academic, industrial, and governmental agencies. In this perspective, examples of the progress and the prospects for the future of molecular imaging and linked targeted therapeutics are reviewed. J. Cell. Biochem. Suppl. 39: 90–97, 2002.

Keywords

This publication has 30 references indexed in Scilit:

Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
Nature Biotechnology, 2001
Novel MRI Contrast Agent for Molecular Imaging of Fibrin
Circulation, 2001
Substituted β-Cyclodextrins Interact with PAMAM Dendrimer–DNA Complexes and Modify Transfection Efficiency
Biochemical and Biophysical Research Communications, 2001
Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles
Magnetic Resonance in Medicine, 2000
Uptake of Radiolabeled 2′-Fluoro-2′-Deoxy-5-Iodo-1-β- d -Arabinofuranosyluracil in Cardiac Cells After Adenoviral Transfer of the Herpesvirus Thymidine Kinase Gene
Circulation, 2000
In vivo visualization of gene expression using magnetic resonance imaging
Nature Biotechnology, 2000
Approaches and agents for imaging the vascular system
Advanced Drug Delivery Reviews, 1999
High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates
Bioconjugate Chemistry, 1999
High-frequency ultrasonic detection of thrombi with a targeted contrast system
Ultrasound in Medicine & Biology, 1997
A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application
Circulation, 1996